Renal Cancers Completed Phase 2 Trials for Capecitabine (DB01101)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

DBCOND0044624 (Renal Cancers)Completed2 IdentifierTitlePurposeDrugs
NCT00042965Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney CancerTreatment
NCT00058318S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) CancerTreatment
NCT00496587Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell CarcinomaTreatment